|
|
|
Insider
Information: |
Invus Public Equities Advisors, Llc |
Relationship: |
10% Owner |
City: |
New York |
State: |
NY |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
7 |
|
Direct
Shares |
32,130,897 |
|
Indirect Shares
|
60,240,864 |
|
|
Direct
Value |
$157,059,461 |
|
|
Indirect Value
|
$107,831,147 |
|
|
Total
Shares |
92,371,761 |
|
|
Total
Value |
$264,890,607 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
15
|
1
|
Stock
price went up :
|
3
|
0
|
Stock
price went down : |
12
|
1
|
|
|
|
Gain/Loss Ratio : |
0.0
|
-1.0
|
Percentage
Gain/Loss : |
-8.7%
|
-25.1%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Lexicon Pharmaceuticals Inc |
LXRX |
Director, 10% Owner |
2014-11-26 |
0 |
2018-06-28 |
60,240,864 |
Premium* |
|
Generation Bio Co. |
GBIO |
10% Owner |
2020-06-16 |
2,814,191 |
2020-06-16 |
0 |
Premium* |
|
Sqz Biotechnologies Co |
SQZ |
10% Owner |
2020-11-03 |
1,606,308 |
2020-11-03 |
0 |
Premium* |
|
Seer, Inc. |
SEER |
10% Owner |
2021-02-01 |
5,588,366 |
2021-02-01 |
0 |
Premium* |
|
Omega Therapeutics, Inc. |
OMGA |
10% Owner |
2021-08-03 |
2,273,530 |
2021-07-30 |
0 |
Premium* |
|
Scholar Rock Holding Corp |
SRRK |
|
2023-10-12 |
11,259,438 |
|
0 |
Premium* |
|
Glycomimetics Inc |
GLYC |
10% Owner |
2023-02-24 |
8,589,064 |
2023-02-09 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
52 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 3
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
SRRK |
Scholar Rock Holding Corp |
10% Owner |
|
2022-06-22 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
8,750,034 |
|
% |
|
GLYC |
Glycomimetics Inc |
10% Owner |
|
2023-02-09 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
6,562,347 |
|
% |
|
SRRK |
Scholar Rock Holding Corp |
10% Owner |
|
2023-01-09 |
4 |
S |
$9.48 |
$10,373 |
D/D |
(1,094) |
9,027,950 |
0 |
% |
|
LXRX |
Lexicon Pharmaceuticals I... |
Director |
|
2018-06-19 |
4 |
AB |
$13.45 |
$120,819 |
I/I |
8,982 |
3,015,660 |
0 |
- |
|
LXRX |
Lexicon Pharmaceuticals I... |
Director |
|
2018-06-14 |
4 |
AB |
$12.66 |
$116,462 |
I/I |
9,200 |
2,970,094 |
0 |
- |
|
GLYC |
Glycomimetics Inc |
10% Owner |
|
2023-02-09 |
4 |
B |
$3.24 |
$37,123 |
D/D |
11,451 |
6,573,798 |
2.37 |
% |
|
LXRX |
Lexicon Pharmaceuticals I... |
Director |
|
2018-06-20 |
4 |
AB |
$13.28 |
$164,613 |
I/I |
12,391 |
3,028,051 |
0 |
- |
|
LXRX |
Lexicon Pharmaceuticals I... |
Director |
|
2018-06-22 |
4 |
AB |
$13.36 |
$340,090 |
I/I |
25,461 |
3,105,112 |
0 |
- |
|
LXRX |
Lexicon Pharmaceuticals I... |
Director |
|
2018-06-08 |
4 |
AB |
$12.89 |
$383,427 |
I/I |
29,747 |
2,755,245 |
0 |
- |
|
SRRK |
Scholar Rock Holding Corp |
10% Owner |
|
2023-04-28 |
4 |
B |
$6.43 |
$202,845 |
D/D |
31,557 |
9,059,507 |
2.45 |
% |
|
SRRK |
Scholar Rock Holding Corp |
10% Owner |
|
2022-10-03 |
4 |
B |
$7.03 |
$238,789 |
D/D |
33,971 |
8,784,005 |
2.45 |
% |
|
LXRX |
Lexicon Pharmaceuticals I... |
Director |
|
2018-06-18 |
4 |
AB |
$13.06 |
$477,937 |
I/I |
36,584 |
3,006,678 |
0 |
- |
|
SRRK |
Scholar Rock Holding Corp |
10% Owner |
|
2023-01-05 |
4 |
B |
$9.33 |
$455,091 |
D/D |
48,774 |
9,029,044 |
2.45 |
% |
|
LXRX |
Lexicon Pharmaceuticals I... |
Director |
|
2017-11-17 |
4 |
AB |
$9.85 |
$492,500 |
I/I |
50,000 |
1,550,000 |
0 |
- |
|
GLYC |
Glycomimetics Inc |
10% Owner |
|
2023-02-21 |
4 |
B |
$1.85 |
$92,500 |
D/D |
50,000 |
8,139,064 |
2.45 |
% |
|
LXRX |
Lexicon Pharmaceuticals I... |
Director |
|
2018-06-21 |
4 |
AB |
$13.27 |
$684,613 |
I/I |
51,600 |
3,079,651 |
0 |
- |
|
LXRX |
Lexicon Pharmaceuticals I... |
Director |
|
2018-06-07 |
4 |
AB |
$12.93 |
$742,508 |
I/I |
57,439 |
2,725,498 |
0 |
- |
|
LXRX |
Lexicon Pharmaceuticals I... |
Director |
|
2018-06-28 |
4 |
AB |
$12.45 |
$718,935 |
I/I |
57,724 |
3,516,214 |
0 |
- |
|
SRRK |
Scholar Rock Holding Corp |
10% Owner |
|
2022-10-04 |
4 |
B |
$7.89 |
$520,760 |
D/D |
66,000 |
8,850,005 |
2.45 |
% |
|
OMGA |
Omega Therapeutics, Inc. |
10% Owner |
|
2021-07-30 |
4 |
B |
$16.14 |
$1,210,343 |
D/D |
75,000 |
75,000 |
2.45 |
- |
|
LXRX |
Lexicon Pharmaceuticals I... |
Director |
|
2018-06-06 |
4 |
AB |
$12.58 |
$1,196,370 |
I/I |
95,079 |
2,668,059 |
0 |
- |
|
LXRX |
Lexicon Pharmaceuticals I... |
Director |
|
2018-06-11 |
4 |
AB |
$12.75 |
$1,257,452 |
I/I |
98,626 |
2,853,871 |
0 |
- |
|
GLYC |
Glycomimetics Inc |
10% Owner |
|
2023-02-24 |
4 |
B |
$1.70 |
$170,000 |
D/D |
100,000 |
8,589,064 |
2.45 |
% |
|
LXRX |
Lexicon Pharmaceuticals I... |
Director |
|
2018-06-12 |
4 |
AB |
$12.83 |
$1,373,244 |
I/I |
107,023 |
2,960,894 |
0 |
- |
|
LXRX |
Lexicon Pharmaceuticals I... |
Director |
|
2018-06-04 |
4 |
AB |
$12.24 |
$1,490,576 |
I/I |
121,803 |
2,399,859 |
0 |
- |
|
52 Records found
|
|
Page 1 of 3 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|